|
ILAR -subtype |
Patients evaluated (male/female) |
Arthropathy (male/female) |
Myopathy (male/female) |
Myoarthropathy (male/female) |
No Symptoms (male/female) |
|
rheumatoid factor neg. polyarthritis |
9 = 100% (2/7) |
0 = 0% (0/0) |
3 = 33% (0/3) |
2 = 22% (0/2) |
4 =44% (2/2) |
|
5 = 100% (1/4) |
0 = 0% (0/0) |
2 =40% (1/1) |
1 = 20% (0/1) |
2 = 40% (0/2) |
|
|
6 = 100% (0/6) |
1 = 17% (0/1) |
1 = 17% (0/1) |
2 = 33% (0/2) |
2 = 33% (0/2) |
|
|
4 =100% (1/3) |
1 = 25% (0/1) |
2 = 50% (0/2) |
0 = 0% (0/0) |
1 = 33% (1/0) |
|
|
10 = 100% (6/4) |
1 = 10% (1/0) |
2= 20% (1/1) |
4 = 40% (2/2) |
3 = 30% (2/1) |
Conclusion: At present, the ILAR classification is the international standardized system. To the best of our knowledge, this is the first study using this classification to investigate TMJ disorders in JIA patients. Further studies are required to evaluate if there is a correlation between TMJ involvement and the different ILAR subgroups.